Melike Mut
- Genetics top 5%
- Glioma Diagnosis and Treatment 13
- Neurology top 5%
- Traumatic Brain Injury and Neurovascular Disturbances 7
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 7
- Pharmaceutical Science top 10%
-
- Brain Metastases and Treatment 6
-
- Meningioma and schwannoma management 8
-
- Spinal Dysraphism and Malformations 7
-
- Nanoplatforms for cancer theranostics 5
-
- Cerebrospinal fluid and hydrocephalus 5
- Co-authors
- Mark E. ShaffreyDavid SchiffFigen SöylemezoğluAyşenur CilaNejat AkalanSelçuk PalaoğluKader Karlı OğuzBurçe Özgen
- Cited by
- GeneticsNeurologyBiomaterials
- Journals
- Journal of Neuro-Oncology (3 papers)Journal of neurosurgery (3 papers)Neurosurgery (2 papers)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Melike Mut
63 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 123
- Genetics 311
- Neurology 241
- Biomaterials 123
- Pharmaceutical Science 51
- Pulmonary and Respiratory Medicine 242
Countries citing papers authored by Melike Mut
This map shows the geographic impact of Melike Mut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melike Mut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melike Mut more than expected).
Fields of papers citing papers by Melike Mut
This network shows the impact of papers produced by Melike Mut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melike Mut. The network helps show where Melike Mut may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Melike Mut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 7 | |
| 5 | 2022 | 0 | |
| 6 | 2020 | 37 | |
| 7 | 2012 | 54 | |
| 8 | 2011 | 70 | |
| 9 | 2011 | 18 | |
| 10 | 2010 | 40 | |
| 11 | 2008 | 27 | |
| 12 | 2007 | 11 | |
| 13 | 2005 | 1 | |
| 14 | 2005 | 12 | |
| 15 | 2005 | 78 | |
| 16 | 2004 | 55 | |
| 17 | 2004 | 23 | |
| 18 | 2003 | 23 | |
| 19 | 2000 | 36 | |
| 20 | 1999 | 3 |
About Melike Mut
Melike Mut is a scholar working on Neurology, Genetics, Developmental Neuroscience, Biomaterials and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (13 papers), Meningioma and schwannoma management (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Spinal Dysraphism and Malformations (7 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers), Brain Metastases and Treatment (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Cerebrospinal fluid and hydrocephalus (5 papers). The work is most often cited by research in Genetics (311 citations), Neurology (241 citations), Biomaterials (123 citations), Pharmaceutical Science (51 citations) and Pulmonary and Respiratory Medicine (242 citations). Melike Mut has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Mark E. Shaffrey, David Schiff, Figen Söylemezoğlu, Ayşenur Cila, Nejat Akalan, Selçuk Palaoğlu, Kader Karlı Oğuz, Kader Karlı Oğuz, Burçe Özgen and Isa M. Hussaini. Their work appears in journals such as Journal of Neuro-Oncology, Journal of neurosurgery, Neurosurgery, Journal of Neurosurgery Spine and Clinical Neurology and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.